Cover Image
市場調查報告書

骨移植、替代骨:開發平台分析

Bone Grafts and Substitutes - Medical Devices Pipeline Assessment, 2017

出版商 GlobalData 商品編碼 344260
出版日期 內容資訊 英文 437 Pages
訂單完成後即時交付
價格
Back to Top
骨移植、替代骨:開發平台分析 Bone Grafts and Substitutes - Medical Devices Pipeline Assessment, 2017
出版日期: 2017年09月12日 內容資訊: 英文 437 Pages
簡介

本報告提供全球各國的企業、醫療機關等開發中的骨移植片及替代骨 (替代骨移植片) 的開發中產品資訊相關分析、臨床實驗/產品開發的整體進展,及各階段/各領域/各地區的詳細趨勢、各企業、各產品的詳細資訊 (臨床實驗的進展階段、開始/結束時期、認證預測等)、近來的產品開發的動向、產業趨勢等資料,為您概述為以下內容。

第1章 目錄

第2章 簡介

第3章 開發中的產品

  • 開發中產品:各開發階段
  • 開發中產品:各領域
  • 開發中產品:各地區
  • 開發中產品:各法規途徑
  • 開發中產品:各認證時期 (估計)
  • 現在進行中的臨床實驗

第4章 骨移植、替代骨:現在開發中的開發中產品 (各企業)

  • 骨移植、替代骨的開發企業:開發中產品 (各開發階段)
  • 骨移植、替代骨:各開發階段的開發中產品一覽

第5章 骨移植、替代骨的企業、產品概要

  • aap Implantate AG
    • 開發中產品及現在進行中的臨床實驗概要
  • Accelerated Orthopedic Technologies, Inc.
  • Adaptaide Inc.
  • Adocia
  • Advanced Biologics, LLC
  • Agenta Biotechnologies, Inc.
  • Allergan, Inc.
  • Alphatec Holdings, Inc.
  • Amedica Corporation
  • Anika Therapeutics, Inc.
  • ApaTech Limited (Inactive)
  • Aperion Biologics Corporation
  • Arthro Kinetics AG
  • Aursos, Inc
  • Berkeley Advanced Biomaterials, Inc.
  • Bio2 Technologies, Inc.
  • Bioactive Bone Substitutes Ltd.
  • Bioregeneration Technologies, Inc
  • Bio-Scaffold International Pte Ltd
  • BioSET, Inc
  • Bioventus LLC
  • Body Organ Biomedical Corp.
  • Bone Solutions, Inc.
  • BoneGrafix, Inc.
  • BoneSupport AB
  • Calcitec, Inc.
  • Cellright Technologies, LLC
  • CeraPedics, Inc.
  • Chinese University of Hong Kong
  • Citrics Biomedical, LLC
  • CollPlant Ltd.
  • ConMed Corporation
  • CoreBone Ltd.
  • ElutInc
  • EpiBone
  • Exactech, Inc.
  • Graftoss Limited
  • Graftys SAS
  • Inion Oy
  • Innovia LLC
  • Innovoss Inc.
  • Integra LifeSciences Holdings Corporation
  • ISTO Technologies, Inc.
  • Jellagen Pty Ltd
  • kasios sas
  • Kensey Nash Corporation (Inactive)
  • Kytogenics Pharmaceuticals, Inc.
  • Lacerta Technologies GmbH
  • Mariel Therapeutics, Inc.
  • Maxigen Biotech Inc.
  • Medtronic plc
  • Meta Biomed Co., Ltd.
  • Miromatrix Medical Inc.
  • N2 Biomedical
  • National Center of Innovation for Biomaterials in Orthopaedic Research
  • Noraker
  • NovaBone Products, LLC.
  • Nutech Medical, Inc
  • NuVasive, Inc.
  • Orthogen LLC
  • OssiFi, Inc.
  • OsteoNovus, LLC
  • PolyPid, Ltd.
  • Promimic AB
  • ReCaPP
  • RepRegen Ltd. (Inactive)
  • Revivicor, Inc.
  • RTI Surgical, Inc.
  • Sanofi
  • SIRAKOSS Limited
  • Soft Tissue Regeneration, Inc.
  • Soteira Inc.
  • Spineway
  • SurgaColl Technologies Ltd
  • TBF Genie Tissulaire
  • The Johns Hopkins University
  • Tissue Regeneration Systems, Inc.
  • Trinity College Dublin
  • University of California, San Diego
  • University of Edinburgh
  • University of Memphis
  • University of Nottingham's School Of Pharmacy
  • University of Pecs
  • University of South Florida
  • Wayne State University
  • Wound Management Technologies, Inc.
  • Wright Medical Group, Inc.
  • X-spine Systems, Inc.
  • Xtant Medical Holdings, Inc.

第6章 骨移植、替代骨:近來的市場趨勢

第7章 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDME0451EPD

GlobalData's Medical Devices sector report, "Bone Grafts and Substitutes - Medical Devices Pipeline Assessment, 2017" provides an overview of Bone Grafts and Substitutes currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Bone Grafts and Substitutes pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Bone Grafts and Substitutes under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Bone Grafts and Substitutes and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • - Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • - Identify and understand important and diverse types of Bone Grafts and Substitutes under development
  • - Develop market-entry and market expansion strategies
  • - Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • - In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 10
  • 1.2 List of Figures 18

2 Introduction 19

  • 2.1 Bone Grafts and Substitutes Overview 19

3 Products under Development 20

  • 3.1 Bone Grafts and Substitutes - Pipeline Products by Stage of Development 20
  • 3.2 Bone Grafts and Substitutes - Pipeline Products by Segment 21
  • 3.3 Bone Grafts and Substitutes - Pipeline Products by Territory 22
  • 3.4 Bone Grafts and Substitutes - Pipeline Products by Regulatory Path 23
  • 3.5 Bone Grafts and Substitutes - Pipeline Products by Estimated Approval Date 24
  • 3.6 Bone Grafts and Substitutes - Ongoing Clinical Trials 25

4 Bone Grafts and Substitutes - Pipeline Products under Development by Companies 26

  • 4.1 Bone Grafts and Substitutes Companies - Pipeline Products by Stage of Development 26
  • 4.2 Bone Grafts and Substitutes - Pipeline Products by Stage of Development 30

5 Bone Grafts and Substitutes Companies and Product Overview 34

  • 5.1 Accelerated Orthopedic Technologies, Inc. Company Overview 34
  • 5.2 Adaptaide Inc. Company Overview 35
  • 5.3 Adocia SAS Company Overview 36
  • 5.4 Advanced Biologics LLC Company Overview 39
  • 5.5 Aeon Astron Corporation Company Overview 40
  • 5.6 Agenta Biotechnologies Inc Company Overview 41
  • 5.7 Allegra Orthopaedics Ltd Company Overview 42
  • 5.8 Alphatec Holdings Inc Company Overview 43
  • 5.9 Amend Surgical, Inc. Company Overview 44
  • 5.10 Anika Therapeutics Inc Company Overview 45
  • 5.11 Antibe Therapeutics Inc Company Overview 47
  • 5.12 Aperion Biologics Corp Company Overview 49
  • 5.13 Arthro Kinetics AG Company Overview 54
  • 5.14 Aursos, Inc (Inactive) Company Overview 55
  • 5.15 Baxter International Inc Company Overview 56
  • 5.16 Berkeley Advanced Biomaterials Inc Company Overview 58
  • 5.17 Bio2 Technologies, Inc. Company Overview 60
  • 5.18 Bioactive Bone Substitutes Ltd Company Overview 61
  • 5.19 Bioregeneration Technologies, Inc Company Overview 64
  • 5.20 Bio-Scaffold International Pte Ltd Company Overview 65
  • 5.21 BioSET Inc Company Overview 68
  • 5.22 Bioventus LLC Company Overview 69
  • 5.23 Bone Solutions Inc Company Overview 71
  • 5.24 BoneGrafix, Inc. Company Overview 74
  • 5.25 BoneSupport AB Company Overview 75
  • 5.26 Calcitec, Inc. Company Overview 79
  • 5.27 Carmell Therapeutics Corp Company Overview 80
  • 5.28 CeraPedics Inc Company Overview 81
  • 5.29 Chinese University of Hong Kong Company Overview 82
  • 5.30 Citrics Biomedical, LLC (Inactive) Company Overview 83
  • 5.31 Collagen Solutions Plc Company Overview 84
  • 5.32 CollPlant Ltd Company Overview 85
  • 5.33 Colorado Therapeutics, LLC Company Overview 87
  • 5.34 ConMed Corporation Company Overview 88
  • 5.35 curasan AG Company Overview 89
  • 5.36 Daewoong Pharmaceutical Co Ltd Company Overview 92
  • 5.37 DSM Biomedical BV Company Overview 93
  • 5.38 Element Orthopedics, Inc. Company Overview 94
  • 5.39 ElutInc Company Overview 95
  • 5.40 Ember Therapeutics Inc Company Overview 96
  • 5.41 EpiBone Inc Company Overview 97
  • 5.42 Exactech Inc Company Overview 98
  • 5.43 Ferring Pharmaceuticals A/S Company Overview 99
  • 5.44 Graftoss Limited Company Overview 103
  • 5.45 Graftys SA Company Overview 104
  • 5.46 Inion Oy Company Overview 108
  • 5.47 Innovia LLC Company Overview 109
  • 5.48 Innovoss Inc. Company Overview 110
  • 5.49 Isto Biologics Company Overview 111
  • 5.50 Jellagen Pty Ltd Company Overview 112
  • 5.51 John Hopkins University Company Overview 113
  • 5.52 kasios sas Company Overview 114
  • 5.53 King's College London Company Overview 116
  • 5.54 Kuros Biosciences AG Company Overview 117
  • 5.55 Kytogenics Pharmaceuticals Inc Company Overview 121
  • 5.56 Lattice Biologics Ltd Company Overview 122
  • 5.57 Maxigen Biotech Inc Company Overview 124
  • 5.58 Medisse BV (Inactive) Company Overview 127
  • 5.59 Medtronic plc Company Overview 128
  • 5.60 Meta Biomed Co Ltd Company Overview 133
  • 5.61 Miromatrix Medical Inc Company Overview 134
  • 5.62 N2 Biomedical Company Overview 135
  • 5.63 National Center of Innovation for Biomaterials in Orthopaedic Research Company Overview 136
  • 5.64 NovaBone Products LLC Company Overview 137
  • 5.65 Nutech Medical Inc Company Overview 138
  • 5.66 NuVasive Inc Company Overview 139
  • 5.67 Orthocell Ltd Company Overview 142
  • 5.68 Orthogem Company Overview 146
  • 5.69 Orthogen LLC Company Overview 147
  • 5.70 Orthosera GmbH Company Overview 148
  • 5.71 OssiFi, Inc. Company Overview 149
  • 5.72 OsteoNovus, LLC Company Overview 150
  • 5.73 PolyPid Ltd Company Overview 152
  • 5.74 Promimic AB Company Overview 155
  • 5.75 ReCaPP Company Overview 156
  • 5.76 RepRegen Ltd. (Inactive) Company Overview 157
  • 5.77 Revivicor Inc Company Overview 159
  • 5.78 RTI Surgical Inc Company Overview 160
  • 5.79 San Raffaele hospital Company Overview 161
  • 5.80 Scil Technology GmbH Company Overview 162
  • 5.81 SeaSpine, Inc. Company Overview 163
  • 5.82 SIRAKOSS Ltd Company Overview 165
  • 5.83 Sofregen Medical Inc Company Overview 167
  • 5.84 Soft Tissue Regeneration Inc Company Overview 169
  • 5.85 Soteira Inc Company Overview 170
  • 5.86 SurgaColl Technologies Ltd Company Overview 171
  • 5.87 SurGenTec LLC Company Overview 172
  • 5.88 TBF Genie Tissulaire Company Overview 173
  • 5.89 Theragnostic Technologies Inc Company Overview 176
  • 5.90 Tissue Regeneration Systems, Inc. Company Overview 177
  • 5.91 Trinity College Dublin Company Overview 178
  • 5.92 University of California San Diego Company Overview 179
  • 5.93 University of Edinburgh Company Overview 180
  • 5.94 University of Malaya Company Overview 181
  • 5.95 University of Maryland Company Overview 182
  • 5.96 University of Memphis Company Overview 183
  • 5.97 University of Nottingham's School Of Pharmacy Company Overview 184
  • 5.98 University of Pecs Company Overview 185
  • 5.99 University of South Florida Company Overview 186
  • 5.100 Vericel Corp Company Overview 187
  • 5.101 Wayne State University Company Overview 188
  • 5.102 Wound Management Technologies Inc Company Overview 189
  • 5.103 Wright Medical Group NV Company Overview 190
  • 5.104 X-spine Systems Inc Company Overview 195
  • 5.105 Xtant Medical Holdings Inc Company Overview 196

6 Bone Grafts and Substitutes- Recent Developments 198

  • 6.1 Aug 31, 2017: Bone Therapeutics Appoints Jean-Luc Vandebroek as Chief Financial Officer 198
  • 6.2 Aug 31, 2017: Bone Therapeutics Announces H1 Results for 2017 198
  • 6.3 Aug 29, 2017: Globus Medical Appoints David M. Demski as CEO 200
  • 6.4 Aug 29, 2017: NuVasive Announces World-Class Innovation Center At San Diego Headquarters 200
  • 6.5 Aug 29, 2017: Antibe Therapeutics Reports Q1 2018 Interim Financial and Operating Results 201
  • 6.6 Aug 28, 2017: Kuros receives clearance for MagnetOs Putty for commercialization in the United States and files the product for CE marking in Europe 202
  • 6.7 Aug 28, 2017: Anika Announces Appointment of Steven Chartier as Vice President of Regulatory and Clinical Affairs 203
  • 6.8 Aug 25, 2017: Sr-­HT-­Gahnite Bone Substitute Project Update 203
  • 6.9 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 204
  • 6.10 Aug 17, 2017: BONESUPPORT Holding: Interim Report January - June 2017 206
  • 6.11 Aug 15, 2017: NuVasive Appoints Rajesh J. Asarpota As Chief Financial Officer 207
  • 6.12 Aug 14, 2017: Governor McAuliffe Announces LifeNet Health to Invest $12.25 million, Create 321 New Jobs in City of Virginia Beach 208
  • 6.13 Aug 14, 2017: aap: Q2 sales and EBITDA in line with guidance; 14% sales growth in trauma in H1/2017aap: Q2 sales and EBITDA in line with guidance; 14% sales growth in trauma in H1/2017Berlin, 14 August 2017 209
  • 6.14 Aug 10, 2017: Alphatec Holdings Reports Second Quarter 2017 Financial Results 210
  • 6.15 Aug 09, 2017: Xtant Medical Reports Second Quarter 2017 Financial Results 212
  • 6.16 Aug 09, 2017: Athersys Reports Second Quarter 2017 Results 213
  • 6.17 Aug 09, 2017: Novadaq Receives Court Approval for Arrangement With Stryker 214
  • 6.18 Aug 08, 2017: RTI Surgical Announces 2017 Second Quarter Results 214
  • 6.19 Aug 07, 2017: Orthofix International Reports Second Quarter 2017 Financial Results 216
  • 6.20 Aug 07, 2017: Bioventus Names Greg Anglum Senior Vice President and Chief Financial Officer, Tony D'Adamio Senior Vice President and General Counsel 217
  • 6.21 Aug 03, 2017: SurGenTec's GRAFTGUN Receives Core Patent for Post Filling Cages Using Their Graft Delivery Technology 217
  • 6.22 Aug 02, 2017: Globus Medical Reports Second Quarter 2017 Results 218
  • 6.23 Aug 02, 2017: Wright Medical Group Reports 2017 Second Quarter Financial Results 219
  • 6.24 Aug 02, 2017: Stryker announces election of new Director, Mary K. Brainerd 221
  • 6.25 Aug 01, 2017: AlloSource Releases AlloFuse Line Extension 222
  • 6.26 Jul 27, 2017: Hoya Reports First Quarter Financial Results 222
  • 6.27 Jul 27, 2017: Zimmer Biomet Reports Second Quarter 2017 Financial Results 223
  • 6.28 Jul 27, 2017: Smith & Nephew Second Quarter and First Half 2017 Results 224
  • 6.29 Jul 27, 2017: Stryker reports second quarter 2017 results 227
  • 6.30 Jul 27, 2017: Anika Announces Appointment of Joseph Darling as President 228
  • 6.31 Jul 27, 2017: Exactech Q2 Revenue $67.3 Million On Continuing Strong Extremities Revenue 229
  • 6.32 Jul 27, 2017: NuVasive Announces New Organizational Structure To Drive Growth And Profitability Goals 230
  • 6.33 Jul 27, 2017: NuVasive Reports Second Quarter 2017 Financial Results 231
  • 6.34 Jul 26, 2017: Adocia Announces Appointment of Dr. Stanislav Glezer as Chief Medical Officer 232
  • 6.35 Jul 26, 2017: Baxter Reports Second-Quarter 2017 Results and Provides Updated Financial Outlook for 2017 and 2020 233
  • 6.36 Jul 26, 2017: Integra LifeSciences Reports Second Quarter 2017 Financial Results 235
  • 6.37 Jul 26, 2017: Anika Reports Strong Second Quarter 2017 Financial Results 236
  • 6.38 Jul 26, 2017: CONMED Announces Second Quarter 2017 Financial Results 237
  • 6.39 Jul 25, 2017: Collagen Solutions: Transitioning to accelerated sustainable growth 238
  • 6.40 Jul 20, 2017: Wound Management Technologies Announces Q2 2017 Sales Up 15% over Q2 2016 and All Amortized Debt Retired in the Second Quarter 245
  • 6.41 Jul 19, 2017: Adocia Presents First Half 2017 Financial Results 245
  • 6.42 Jul 18, 2017: Spineway: Confirmed growth Revenue for the first half of 2017: €6M (+146%) 247
  • 6.43 Jul 17, 2017: Baxter Appoints Cathy R. Smith to its Board 248
  • 6.44 Jul 11, 2017: Zimmer Biomet Announces Leadership Transition 248
  • 6.45 Jul 11, 2017: Zimmer Biomet Reports Certain Preliminary Second Quarter 2017 Results 249
  • 6.46 Jul 11, 2017: Spinal Elements Promotes Jason Blain to President & Chief Operating Officer 249
  • 6.47 Jul 11, 2017: Collagen Solutions: Final Results for the year ended 31 March 2017 250
  • 6.48 Jul 11, 2017: Medicrea Reports First Half 2017 Sales 251
  • 6.49 Jul 06, 2017: Lattice Biologics Announces Change in Director and Chairman of Scientific Advisory Board 251
  • 6.50 Jul 04, 2017: Appointment of Angie Risley as Non-Executive Director and Chairman Elect of the Remuneration Committee 252
  • 6.51 Jul 03, 2017: Bone Therapeutics Strengthens Board of Directors 252

7 Appendix 432

  • 7.1 Methodology 432
  • 7.2 About GlobalData 435
  • 7.3 Contact Us 435
  • 7.4 Disclaimer 435

List of Tables

1.1 List of Tables

  • Table 1: Bone Grafts and Substitutes - Pipeline Products by Stage of Development 22
  • Table 2: Bone Grafts and Substitutes - Pipeline Products by Segment 23
  • Table 3: Bone Grafts and Substitutes - Pipeline Products by Territory 24
  • Table 4: Bone Grafts and Substitutes - Pipeline Products by Regulatory Path 25
  • Table 5: Bone Grafts and Substitutes - Pipeline Products by Estimated Approval Date 26
  • Table 6: Bone Grafts and Substitutes - Ongoing Clinical Trials 27
  • Table 7: Bone Grafts and Substitutes Companies - Pipeline Products by Stage of Development 28
  • Table 8: Bone Grafts and Substitutes - Pipeline Products by Stage of Development 32
  • Table 9: Accelerated Orthopedic Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 36
  • Table 10: Cartilage Lesions Repair Device - Product Status 36
  • Table 11: Cartilage Lesions Repair Device - Product Description 36
  • Table 12: Adaptaide Inc. Pipeline Products & Ongoing Clinical Trials Overview 37
  • Table 13: Super-Inductive DBM - Product Status 37
  • Table 14: Super-Inductive DBM - Product Description 37
  • Table 15: Adocia SAS Pipeline Products & Ongoing Clinical Trials Overview 38
  • Table 16: BioChaperone BMP - Degenerative Disc Disease - Product Status 38
  • Table 17: BioChaperone BMP - Degenerative Disc Disease - Product Description 38
  • Table 18: Biochaperone BMP - Non-Union Fractures - Product Status 39
  • Table 19: Biochaperone BMP - Non-Union Fractures - Product Description 39
  • Table 20: BioChaperone BMP - Osteoporosis - Product Status 39
  • Table 21: BioChaperone BMP - Osteoporosis - Product Description 40
  • Table 22: Advanced Biologics LLC Pipeline Products & Ongoing Clinical Trials Overview 41
  • Table 23: OsteoMEM Synthetic Bone Graft Substitute - Product Status 41
  • Table 24: OsteoMEM Synthetic Bone Graft Substitute - Product Description 41
  • Table 25: Aeon Astron Corporation Pipeline Products & Ongoing Clinical Trials Overview 42
  • Table 26: BioBone Filler - Product Status 42
  • Table 27: BioBone Filler - Product Description 42
  • Table 28: Agenta Biotechnologies Inc Pipeline Products & Ongoing Clinical Trials Overview 43
  • Table 29: B-247 Cranial Bone Graft Implant - Product Status 43
  • Table 30: B-247 Cranial Bone Graft Implant - Product Description 43
  • Table 31: Allegra Orthopaedics Ltd Pipeline Products & Ongoing Clinical Trials Overview 44
  • Table 32: Sr-HT-Gahnite Bone Substitute - Product Status 44
  • Table 33: Sr-HT-Gahnite Bone Substitute - Product Description 44
  • Table 34: Alphatec Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 45
  • Table 35: Bonex - Product Status 45
  • Table 36: Bonex - Product Description 45
  • Table 37: Amend Surgical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 46
  • Table 38: Biomimetic Bone - Product Status 46
  • Table 39: Biomimetic Bone - Product Description 46
  • Table 40: Anika Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 47
  • Table 41: Hyalobone - Product Status 47
  • Table 42: Hyalobone - Product Description 47
  • Table 43: Hyalonect - Product Status 48
  • Table 44: Hyalonect - Product Description 48
  • Table 45: Antibe Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 49
  • Table 46: CGX-227 - Product Status 49
  • Table 47: CGX-227 - Product Description 49
  • Table 48: CGX-443 - Product Status 50
  • Table 49: CGX-443 - Product Description 50
  • Table 50: Aperion Biologics Corp Pipeline Products & Ongoing Clinical Trials Overview 51
  • Table 51: Z-Fix - Product Status 51
  • Table 52: Z-Fix - Product Description 51
  • Table 53: Z-Lig BT+ - Product Status 52
  • Table 54: Z-Lig BT+ - Product Description 52
  • Table 55: Z-Lig BTB - Product Status 52
  • Table 56: Z-Lig BTB - Product Description 53
  • Table 57: Z-Lig ST - Product Status 53
  • Table 58: Z-Lig ST - Product Description 53
  • Table 59: Z-Meniscus - Product Status 54
  • Table 60: Z-Meniscus - Product Description 54
  • Table 61: Z-Patch - Product Status 54
  • Table 62: Z-Patch - Product Description 55
  • Table 63: Arthro Kinetics AG Pipeline Products & Ongoing Clinical Trials Overview 56
  • Table 64: CaReS plus - Product Status 56
  • Table 65: CaReS plus - Product Description 56
  • Table 66: Aursos, Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 57
  • Table 67: AUR-84 Resorbable Implant - Product Status 57
  • Table 68: AUR-84 Resorbable Implant - Product Description 57
  • Table 69: Baxter International Inc Pipeline Products & Ongoing Clinical Trials Overview 58
  • Table 70: INDUCTIGRAFT - Product Status 58
  • Table 71: INDUCTIGRAFT - Product Description 58
  • Table 72: Synthetic Bone Graft - Orthopaedic - Product Status 59
  • Table 73: Synthetic Bone Graft - Orthopaedic - Product Description 59
  • Table 74: Synthetic Bone Graft - Spinal - Product Status 59
  • Table 75: Synthetic Bone Graft - Spinal - Product Description 59
  • Table 76: Berkeley Advanced Biomaterials Inc Pipeline Products & Ongoing Clinical Trials Overview 60
  • Table 77: CPA Ceramics - Product Status 60
  • Table 78: CPA Ceramics - Product Description 60
  • Table 79: HAP Ceramics - Product Status 61
  • Table 80: HAP Ceramics - Product Description 61
  • Table 81: Bio2 Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 62
  • Table 82: Hammertoe Intramedullary Fusion Device - Product Status 62
  • Table 83: Hammertoe Intramedullary Fusion Device - Product Description 62
  • Table 84: Bioactive Bone Substitutes Ltd Pipeline Products & Ongoing Clinical Trials Overview 63
  • Table 85: ARTEBONE - Product Status 63
  • Table 86: ARTEBONE - Product Description 63
  • Table 87: Bone Graft Substitute - Blocks - Product Status 64
  • Table 88: Bone Graft Substitute - Blocks - Product Description 64
  • Table 89: Bone Graft Substitute - Granules - Product Status 64
  • Table 90: Bone Graft Substitute - Granules - Product Description 65
  • Table 91: Bioregeneration Technologies, Inc Pipeline Products & Ongoing Clinical Trials Overview 66
  • Table 92: InMotion - Product Status 66
  • Table 93: InMotion - Product Description 66
  • Table 94: Bio-Scaffold International Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 67
  • Table 95: BMP And Growth Factor Loaded Scaffold - Orthodontic Oral/Maxillofacial Surgery - Product Status 67
  • Table 96: BMP And Growth Factor Loaded Scaffold - Orthodontic Oral/Maxillofacial Surgery - Product Description 67
  • Table 97: BMP And Growth Factor Loaded Scaffold - Orthopaedic Surgery - Product Status 68
  • Table 98: BMP And Growth Factor Loaded Scaffold - Orthopaedic Surgery - Product Description 68
  • Table 99: BMP And Growth Factor Loaded Scaffold - Plastic/Reconstructive Surgery - Product Status 68
  • Table 100: BMP And Growth Factor Loaded Scaffold - Plastic/Reconstructive Surgery - Product Description 69
  • Table 101: BioSET Inc Pipeline Products & Ongoing Clinical Trials Overview 70
  • Table 102: AMPLEX Osteo-Promotive Bone Graft System - Lumbar Spine Fusion - Product Status 70
  • Table 103: AMPLEX Osteo-Promotive Bone Graft System - Lumbar Spine Fusion - Product Description 70
  • Table 104: Bioventus LLC Pipeline Products & Ongoing Clinical Trials Overview 71
  • Table 105: OsteoAMP - Concentrate - Product Status 71
  • Table 106: OsteoAMP - Concentrate - Product Description 71
  • Table 107: OsteoAMP - Structural - Product Status 71
  • Table 108: OsteoAMP - Structural - Product Description 72
  • Table 109: Bone Solutions Inc Pipeline Products & Ongoing Clinical Trials Overview 73
  • Table 110: Osteocrete - Bone Anchor - Product Status 73
  • Table 111: Osteocrete - Bone Anchor - Product Description 73
  • Table 112: OsteoCrete - Cranial - Product Status 74
  • Table 113: OsteoCrete - Cranial - Product Description 74
  • Table 114: OsteoCrete - Maxillofacial - Product Status 74
  • Table 115: OsteoCrete - Maxillofacial - Product Description 75
  • Table 116: OsteoCrete - Non Load Bearing Spine - Product Status 75
  • Table 117: OsteoCrete - Non Load Bearing Spine - Product Description 75
  • Table 118: BoneGrafix, Inc. Pipeline Products & Ongoing Clinical Trials Overview 76
  • Table 119: Solid Bone Block - Product Status 76
  • Table 120: Solid Bone Block - Product Description 76
  • Table 121: BoneSupport AB Pipeline Products & Ongoing Clinical Trials Overview 77
  • Table 122: Cerament|G - Product Status 77
  • Table 123: Cerament|G - Product Description 77
  • Table 124: BoneSupport AB - Ongoing Clinical Trials Overview 78
  • Table 125: Cerament|G - A Prospective Clinical Outcome Study of a New Biphasic Absorbable Composite Carrier with Gentamicin in the Treatment of Chronic Osteomyelitis 79
  • Table 126: Cerament|G - A Prospective, Randomized Multicenter Controlled Trial of CERAMENT|G as Part of Surgical Repair of Open Diaphyseal Tibial Fractures 79
  • Table 127: Cerament|G - CERAMENT lBONE VOID FILLER and gentamicin eluting CERAMENT lG for Prophylactic Use in Bone Tumor Patients 79
  • Table 128: Cerament|G - CERAMENT/G - Bone Healing and Re-infection Prophylaxis 80
  • Table 129: Cerament|G - Study to Assess Cerament G as Part of Surgical Repair of Open Diaphyseal Tibial Fractures 80
  • Table 130: Calcitec, Inc. Pipeline Products & Ongoing Clinical Trials Overview 81
  • Table 131: Corticell - Product Status 81
  • Table 132: Corticell - Product Description 81
  • Table 133: Carmell Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview 82
  • Table 134: Bone Healing Accelerant - DBM Spine - Product Status 82
  • Table 135: Bone Healing Accelerant - DBM Spine - Product Description 82
  • Table 136: CeraPedics Inc Pipeline Products & Ongoing Clinical Trials Overview 83
  • Table 137: i-FACTOR Peptide Enhanced Bone Graft - TLIF - Product Status 83
  • Table 138: i-FACTOR Peptide Enhanced Bone Graft - TLIF - Product Description 83
  • Table 139: Chinese University of Hong Kong Pipeline Products & Ongoing Clinical Trials Overview 84
  • Table 140: Osteoinductive Composite Scaffold - Product Status 84
  • Table 141: Osteoinductive Composite Scaffold - Product Description 84
  • Table 142: Citrics Biomedical, LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 85
  • Table 143: CitrOSponge - Product Status 85
  • Table 144: CitrOSponge - Product Description 85
  • Table 145: Collagen Solutions Plc Pipeline Products & Ongoing Clinical Trials Overview 86
  • Table 146: Bone Graft Substitutes - Product Status 86
  • Table 147: Bone Graft Substitutes - Product Description 86
  • Table 148: CollPlant Ltd Pipeline Products & Ongoing Clinical Trials Overview 87
  • Table 149: VergenixBVF - Product Status 87
  • Table 150: VergenixBVF - Product Description 87
  • Table 151: VergenixBVF - Antibiotics - Product Status 88
  • Table 152: VergenixBVF - Antibiotics - Product Description 88
  • Table 153: Colorado Therapeutics, LLC Pipeline Products & Ongoing Clinical Trials Overview 89
  • Table 154: Xenograft Implant - Orthopedic - Product Status 89
  • Table 155: Xenograft Implant - Orthopedic - Product Description 89
  • Table 156: ConMed Corporation Pipeline Products & Ongoing Clinical Trials Overview 90
  • Table 157: Allograft Cartilage Scaffold - Product Status 90
  • Table 158: Allograft Cartilage Scaffold - Product Description 90
  • Table 159: curasan AG Pipeline Products & Ongoing Clinical Trials Overview 91
  • Table 160: Cerasorb Classic Ortho - Product Status 91
  • Table 161: Cerasorb Classic Ortho - Product Description 91
  • Table 162: Cerasorb M Ortho - Product Status 92
  • Table 163: Cerasorb M Ortho - Product Description 92

List of Figures

1.2 List of Figures

  • Figure 1: Bone Grafts and Substitutes - Pipeline Products by Stage of Development 22
  • Figure 2: Bone Grafts and Substitutes - Pipeline Products by Segment 23
  • Figure 3: Bone Grafts and Substitutes - Pipeline Products by Territory 24
  • Figure 4: Bone Grafts and Substitutes - Pipeline Products by Regulatory Path 25
  • Figure 5: Bone Grafts and Substitutes - Pipeline Products by Estimated Approval Date 26
  • Figure 6: Bone Grafts and Substitutes - Ongoing Clinical Trials 27
Back to Top